Results 11 to 20 of about 24,121 (231)

Association Between β-Adrenoreceptor Agonists and Antagonists and Parkinson's Disease: Systematic Review and Meta-Analysis. [PDF]

open access: yesPharmacoepidemiol Drug Saf
ABSTRACT Background β‐agonists and β‐antagonists are among the most prescribed drugs worldwide. In 2018, studies suggesting a harmful association between propranolol and Parkinson's disease (PD) prompted a signal procedure by the European Medicines Agency's safety committee, which concluded with no update of product information.
Szmigiel A   +8 more
europepmc   +2 more sources

Prevalence of high flow nasal cannula therapy use for management of infants with bronchiolitis in Australia and New Zealand

open access: yesJournal of Paediatrics and Child Health, Volume 58, Issue 12, Page 2230-2235, December 2022., 2022
Aim To determine the prevalence of high flow nasal cannula (HFNC) therapy in infants presenting to hospital in Australia and New Zealand with bronchiolitis over four bronchiolitis seasons. Secondary aims were to determine temporal trends in HFNC use, and associations between HFNC, hospital length of stay (LOS) and intensive care unit (ICU) admission ...
Sharon O'Brien   +9 more
wiley   +1 more source

(R)-Salbutamol Improves Imiquimod-Induced Psoriasis-Like Skin Dermatitis by Regulating the Th17/Tregs Balance and Glycerophospholipid Metabolism

open access: yesCells, 2020
Psoriasis is a skin disease that is characterized by a high degree of inflammation caused by immune dysfunction. (R)-salbutamol is a bronchodilator for asthma and was reported to alleviate immune system reactions in several diseases. In this study, using
Fei Liu   +4 more
doaj   +1 more source

Inhaled salbutamol induces leanness in well-trained healthy females but not males during a period of endurance training: a randomised controlled trial

open access: yesERJ Open Research, 2023
Introduction Many athletes use short-acting inhaled β2-agonists multiple times weekly during training sessions to prevent exercise-induced bronchoconstriction, but it is unclear if treatment impairs training outcomes.
Morten Hostrup   +5 more
doaj   +1 more source

Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis.

open access: yesPLoS ONE, 2021
BackgroundA combination of ipratropium bromide (IB) and salbutamol is commonly used to treat asthma in children and adolescents; however, there has been a lack of consistency in its usage in clinical practice.ObjectiveTo evaluate the efficacy and safety ...
Hongzhen Xu   +6 more
doaj   +1 more source

Raman enhancement effect of different silver nanoparticles on salbutamol

open access: yesHeliyon, 2022
Salbutamol is a β-adrenergic receptor agonist compound which has been abused as an animal growth promoter to improve carcass lean meat percentage. At present, the detection of salbutamol by SERS mostly uses gold colloid as substrate, which is expensive ...
Qinghui Guo, Yankun Peng, Kuanglin Chao
doaj  

The effects of salbutamol in an experimental model with acute respiratory distress syndrome

open access: yesJournal of Acute Disease, 2012
Objective: To investigate salbutamol effects on histopathologic features of acute respiratory distress syndrome (ARDS). Methods: ARDS was designed in Wistar albino male rats, 250–300 g in weight, by intratracheal instillation of physiological saline ...
Sema Yilmaz   +7 more
doaj   +1 more source

Levosalbutamol as alternative to drugs on the basis of racemic salbutamol: Review of the results of pre-clinical research

open access: yesRegulatory Mechanisms in Biosystems, 2017
The aim of the work is to conduct an analytical review of the results of preclinical studies of levosalbutamol. The review discusses the pharmacodynamic features of the R-stereoisomer of salbutamol in vitro.
A. G. Miroshnichenko   +3 more
doaj   +1 more source

Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine

open access: yesPharmaceutics, 2023
Drug–drug interactions (DDIs) represent a significant concern in healthcare, particularly for patients undergoing polytherapy. DDIs can lead to a range of outcomes, from decreased therapeutic effectiveness to adverse effects. Salbutamol, a bronchodilator
Lara Marques, Nuno Vale
doaj   +1 more source

Salbutamol: beware of the paradox! [PDF]

open access: yesCase Reports, 2010
A 7-year-old known asthmatic presented with an acute severe asthma attack to the Accident and Emergency department. Following a poor response to salbutamol and ipratropium nebulisers, he was given intravenous salbutamol and aminophylline. Over the course of the following 3 h, there was improvement in his bronchospasm with decreasing oxygen requirement,
R Saxena, G Marais
openaire   +3 more sources

Home - About - Disclaimer - Privacy